Cell Robotics' infant heelstick test on the horizon:
This article was originally published in Clinica
Executive Summary
Cell Robotics International plans to introduce its infant lasette healstick for drawing capillary blood from infant's heels later this year. The device, a modification of the firm's lasette finger perforator, vaporises the heel skin in a pinpoint manner. This avoids problems associated with existing blood collection methods, such as excessive puncture depth and contamination of the blood sample with wound debris, said the Albuquerque, New Mexico firm, which plans to submit an FDA 510(k) application by October 2002.
You may also be interested in...
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
ImmunityBio Will Aim Anktiva At Large Share Of Bladder Cancer Market
Execs Richard Adcock and Patrick Soon-Shiong told Scrip the company sees an addressable US population of about 20,000 and is aiming for ease of physician adoption.